Andreas-Claudius Hoffmann

Correction: Generation and Characterisation of Cisplatin-Resistant Non-Small Cell Lung Cancer Cell Lines Displaying a Stem-Like Signature.

Martin P. Barr, Steven G. Gray, Andreas-Claudius Hoffmann et al. · PubMed · 2020 · 273 citations · Full text

Medicine, Oncology, Pharmacology +17

High Expression of HIF1a Is a Predictor of Clinical Outcome in Patients with Pancreatic Ductal Adenocarcinomas and Correlated to PDGFA, VEGF, and bFGF

Andreas-Claudius Hoffmann, Daniel Vallböhmer, Jan Brabender et al. · Neoplasia · 2008 · 145 citations · Full text

Medicine, Oncology, Pathology +13

MDR1 and ERCC1 Expression Predict Outcome of Patients with Locally Advanced Bladder Cancer Receiving Adjuvant Chemotherapy

Andreas-Claudius Hoffmann, Peter J. Wild, Christina Leicht et al. · Neoplasia · 2010 · 137 citations · Full text

Medicine, Oncology, Urology +6

Proteomic Differences Between Hepatocellular Carcinoma and Nontumorous Liver Tissue Investigated by a Combined Gel-based and Label-free Quantitative Proteomics Study

Dominik A. Megger, Thilo Bracht, Michael Kohl et al. · Molecular & Cellular Proteomics · 2013 · 114 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +17

Analysis of Disease-Associated Protein Expression Using Quantitative Proteomics—Fibulin-5 Is Expressed in Association with Hepatic Fibrosis

Thilo Bracht, Vincent Schweinsberg, Martin Trippler et al. · Journal of Proteome Research · 2015 · 77 citations

Medicine, Molecular Biology, Pathology +17